Evidence map›Paper›PMID 28919261›Full record

ArticleStem cell reports2017

Top-Down Inhibition of BMP Signaling Enables Robust Induction of hPSCs Into Neural Crest in Fully Defined, Xeno-free Conditions.

James O S Hackland, Tom J R Frith, Oliver Thompson, Ana Marin Navarro, Martin I Garcia-Castro, Christian Unger, Peter W Andrews

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

James O S HacklandUniversity of California Riverside, Department of Biomedical Sciences, Riverside, CA 92521, USA; University of Sheffield, Department of Biomedical Science, Sheffield S10 2TN, UK. Electronic address: hacklandj@gmail.com.
Tom J R FrithUniversity of Sheffield, Department of Biomedical Science, Sheffield S10 2TN, UK.
Oliver ThompsonUniversity of Sheffield, Department of Biomedical Science, Sheffield S10 2TN, UK.
Ana Marin NavarroKarolinska Institutet, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden; Karolinska Institutet, Department of Neuroscience, Stockholm, Sweden.
Martin I Garcia-CastroUniversity of California Riverside, Department of Biomedical Sciences, Riverside, CA 92521, USA.
Christian UngerUniversity of Sheffield, Department of Biomedical Science, Sheffield S10 2TN, UK.
Peter W AndrewsUniversity of Sheffield, Department of Biomedical Science, Sheffield S10 2TN, UK.
University of Sheffield · GBUniversity of California, Riverside · USKarolinska Institutet · SE

Funding

Molecular Interactions During Neural Crest FormationR01DE017914 · NIDCR · YALE UNIVERSITY · PI GARCIA-CASTRO, MARTIN I. · 2007 to 2025
$6.3M
Medical Research Council MC_PC_14115Medical Research Council MR/L012537/1Medical Research Council MR/L012650/1Medical Research Council R/143416-14-1NIDCR NIH HHS R01 DE017914
6 · The paper itself

Abstract

Defects in neural crest development have been implicated in many human disorders, but information about human neural crest formation mostly depends on extrapolation from model organisms. Human pluripotent stem cells (hPSCs) can be differentiated into in vitro counterparts of the neural crest, and some of the signals known to induce neural crest formation in vivo are required during this process. However, the protocols in current use tend to produce variable results, and there is no consensus as to the precise signals required for optimal neural crest differentiation. Using a fully defined culture system, we have now found that the efficient differentiation of hPSCs to neural crest depends on precise levels of BMP signaling, which are vulnerable to fluctuations in endogenous BMP production. We present a method that controls for this phenomenon and could be applied to other systems where endogenous signaling can also affect the outcome of differentiation protocols.

Indexed as

Cell DifferentiationSignal TransductionBiomarkersBone Morphogenetic ProteinsCells, CulturedEmbryonic Stem CellsGene ExpressionHumansModels, BiologicalNeural CrestPluripotent Stem CellsTranscription FactorsBiomarkersBone Morphogenetic ProteinsTranscription FactorsBMPectodermembryonic stem cellsendogenous signal controlfully defined differentiationhuman pluripotent stem cellsneural crestTDitop-down inhibition

Identifiers

PMID28919261
PMCPMC5639211
OpenAlexW2755736417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.